{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:37:42Z","timestamp":1781822262542,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T00:00:00Z","timestamp":1443398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10384-015-0413-1","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T01:54:26Z","timestamp":1443405266000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Twenty-four-hour efficacy of preservative-free tafluprost for open-angle glaucoma patients, assessed by home intraocular pressure (Icare-ONE) and blood-pressure monitoring"],"prefix":"10.1007","volume":"60","author":[{"given":"Soon Young","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungkwon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"413_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/09286580701501931","volume":"14","author":"MC Leske","year":"2007","unstructured":"Leske MC. Open-angle glaucoma\u2014an epidemiologic overview. Ophthalmic Epidemiol. 2007;14:166\u201372.","journal-title":"Ophthalmic Epidemiol"},{"key":"413_CR2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268\u201379.","journal-title":"Arch Ophthalmol"},{"key":"413_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","volume":"130","author":"The AGIS Investigators","year":"2000","unstructured":"The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): the relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130:429\u201340.","journal-title":"Am J Ophthalmol"},{"key":"413_CR4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u201313.","journal-title":"Arch Ophthalmol"},{"key":"413_CR5","unstructured":"The American Academy of Ophthalmology Panel. Preffered practice pattern guidelines: primary open-angle glaucoma. The American Academy of Ophthalmology. 2010. http:\/\/one.aao.org\/preferred-practice-pattern\/primary-openangle-glaucoma-ppp--october-2010 . Accessed 21 Nov 2014."},{"key":"413_CR6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00061198-200106000-00008","volume":"10","author":"RP Mills","year":"2001","unstructured":"Mills RP, Janz NK, Wren PA, Guire KE. Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma. 2001;10:192\u20138.","journal-title":"J Glaucoma"},{"key":"413_CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00061198-200306000-00009","volume":"12","author":"E Hughes","year":"2003","unstructured":"Hughes E, Spry P, Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma. 2003;12:232\u20136.","journal-title":"J Glaucoma"},{"key":"413_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00417-003-0671-3","volume":"242","author":"A Kontiola","year":"2004","unstructured":"Kontiola A, Puska P. Measuring intraocular pressure with the pulsair 3000 and rebound tonometers in elderly patients without an anesthetic. Graefes Arch Clin Exp Ophthalmol. 2004;242:3\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"413_CR9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1475-1313.2005.00327.x","volume":"25","author":"P Fernandes","year":"2005","unstructured":"Fernandes P, Diaz-Rey JA, Queiros A, Gonzalez-Meijome JM, Jorge J. Comparison of the ICare rebound tonometer with the Goldmann tonometer in a normal population. Ophthalmic Physiol Opt. 2005;25:436\u201340.","journal-title":"Ophthalmic Physiol Opt"},{"key":"413_CR10","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1167\/iovs.05-0586","volume":"46","author":"JM Martinez-de-la-Casa","year":"2005","unstructured":"Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, Garcia-Sanchez J. Reproducibility and clinical evaluation of rebound tonometry. Invest Ophthalmol Vis Sci. 2005;46:4578\u201380.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"413_CR11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.eye.6702669","volume":"22","author":"LM Abraham","year":"2008","unstructured":"Abraham LM, Epasinghe NC, Selva D, Casson R. Comparison of the ICare rebound tonometer with the Goldmann applanation tonometer by experienced and inexperienced tonometrists. Eye. 2008;22:503\u20136.","journal-title":"Eye"},{"key":"413_CR12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/IJG.0b013e3181d78811","volume":"20","author":"S Asrani","year":"2011","unstructured":"Asrani S, Chatterjee A, Wallace DK, Santiago-Turla C, Stinnett S. Evaluation of the ICare rebound tonometer as a home intraocular pressure monitoring device. J Glaucoma. 2011;20:74\u20139.","journal-title":"J Glaucoma"},{"key":"413_CR13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.exer.2003.12.007","volume":"78","author":"Y Takagi","year":"2004","unstructured":"Takagi Y, Nakajima T, Shimazaki A, Kageyama M, Matsugi T, Matsumura Y, et al. Phamacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res. 2004;78:767\u201376.","journal-title":"Exp Eye Res"},{"key":"413_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1755-3768.2010.01907.x","volume":"88","author":"H Uusitalo","year":"2010","unstructured":"Uusitalo H, Chen E, Pfeiffer N, Brignole-Baudouin F, Kaarniranta K, Leino M, et al. Switching from a preserved to a preservative-free prostaglandin preperation in topical glaucoma medication. Acta Ophthalmol. 2010;88:329\u201336.","journal-title":"Acta Ophthalmol"},{"key":"413_CR15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12325-014-0109-9","volume":"31","author":"Y Kuwayama","year":"2014","unstructured":"Kuwayama Y, Nomura A. Prospective observational post-marketing study of tafluprost for glaucoma and ocular hypertension: short-term efficacy and safety. Adv Ther. 2014;31:461\u201371.","journal-title":"Adv Ther"},{"key":"413_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10384-011-0082-7","volume":"55","author":"T Nakano","year":"2011","unstructured":"Nakano T, Yoshikawa K, Kimura T, Suzumura H, Nanno M, Noro T. Efficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16\u00a0mmHg or less. Jpn J Ophthalmol. 2011;55:605\u201313.","journal-title":"Jpn J Ophthalmol"},{"key":"413_CR17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2147\/OPTH.S33414","volume":"6","author":"T Mizoguchi","year":"2012","unstructured":"Mizoguchi T, Ozaki M, Unoki K, Dake Y, Eto T, Arai M. A randomized crossover study comparing tafluprost 0.0015% with travoprost 0.004% in patients with normal-tension glaucoma (corrected). Clin Ophthalmol. 2012;6:1579\u201384.","journal-title":"Clin Ophthalmol"},{"key":"413_CR18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ophtha.2005.01.042","volume":"112","author":"R Valk van der","year":"2005","unstructured":"van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH. Intraocular pressure-lowering effects of all commonly used glaucoma drugs-A meta-analysis of randomized clinical trials. Ophthalmology. 2005;112:1177\u201385.","journal-title":"Ophthalmology"},{"key":"413_CR19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jop.2009.0066","volume":"26","author":"CE Traverso","year":"2010","unstructured":"Traverso CE, Ropo A, Papadia M, Uusitalo H. A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of tafluprost compared with latanoprost. J Ocul Phamacol Ther. 2010;26:97\u2013104.","journal-title":"J Ocul Phamacol Ther."},{"key":"413_CR20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10384-013-0299-8","volume":"58","author":"R Sakata","year":"2014","unstructured":"Sakata R, Shirato S, Miyata K, Aihara M. Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution. Jpn J Ophthalmol. 2014;58:212\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"413_CR21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ajo.2011.11.008","volume":"153","author":"A Chabi","year":"2012","unstructured":"Chabi A, Varma R, Tsai JC, Lupinacci R, Pigeon J, Baranak C, et al. Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2012;153:1187\u201396.","journal-title":"Am J Ophthalmol"},{"key":"413_CR22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/bjophthalmol-2012-303026","volume":"97","author":"AG Konstas","year":"2013","unstructured":"Konstas AG, Quaranta L, Katsanos A, Riva I, Tsai JC, Giannopoulos T, et al. Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension. Br J Ophthalmol. 2013;97:1510\u20135.","journal-title":"Br J Ophthalmol"},{"key":"413_CR23","volume-title":"Automated static perimetry","author":"DR Anderson","year":"1999","unstructured":"Anderson DR, Patella VM. Automated static perimetry. 2nd ed. St. Louis: Mosby; 1999.","edition":"2"},{"key":"413_CR24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0002-9394(98)00019-1","volume":"125","author":"SM Drance","year":"1998","unstructured":"Drance SM, Crichton A, Mills RP. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol. 1998;125:585\u201392.","journal-title":"Am J Ophthalmol"},{"key":"413_CR25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archopht.122.8.1117","volume":"122","author":"J Li","year":"2004","unstructured":"Li J, Herndon LW, Asrani SG, Stinnett S, Allingham RR. Clinical comparison of the proview eye pressure monitor with the Goldmann applanation tonometer and the tonopen. Arch Ophthalmol. 2004;122:1117\u201321.","journal-title":"Arch Ophthalmol"},{"key":"413_CR26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bjo.2010.192922","volume":"95","author":"K Mansouri","year":"2011","unstructured":"Mansouri K, Shaarawy T. Continuous intraocular pressure monitoring with a wireless ocular telemetry sensor: initial clinical experience in patients with open angle glaucoma. Br J Ophthalmol. 2011;95:627\u20139.","journal-title":"Br J Ophthalmol"},{"key":"413_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/IJG.0b013e31802fc6bc","volume":"16","author":"A Sahin","year":"2007","unstructured":"Sahin A, Basmak H, Niyaz L, Yildirim N. Reproducibility and tolerability of the ICare rebound tonometer in school children. J Glaucoma. 2007;16:185\u20138.","journal-title":"J Glaucoma"},{"key":"413_CR28","author":"J Moreno-Montanes","year":"2014","unstructured":"Moreno-Montanes J, Martinez-de-la-Casa JM, Sabater AL, Morales L, Saenz C, Garcia-Feijoo J. Clinical evaluation of the new rebound tonometers Icare PRO and Icare ONE compared with the Goldmann tonometer. J Glaucoma. 2014. doi: 10.1097\/ijg.0000000000000058 .","journal-title":"J Glaucoma"},{"key":"413_CR29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00417-011-1785-7","volume":"249","author":"A Rosentreter","year":"2011","unstructured":"Rosentreter A, Jablonski KS, Mellein AC, Gaki S, Hueber A, Dietlein TS. A new rebound tonometer for home monitoring of intraocular pressure. Graefes Arch Clin Exp Ophthalmol. 2011;249:1713\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"413_CR30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00417-011-1875-6","volume":"250","author":"I Halkiadakis","year":"2012","unstructured":"Halkiadakis I, Stratos A, Stergiopoulos G, Patsea E, Skouriotis S, Mitropoulos P, et al. Evaluation of the Icare-ONE rebound tonometer as a self-measuring intraocular pressure device in normal subjects. Graefes Arch Clin Exp Ophthalmol. 2012;250:1207\u201311.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"413_CR31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1185\/03007995.2010.492030","volume":"26","author":"A Hommer","year":"2010","unstructured":"Hommer A, Mohammed RO, Burchert M, Kimmich F. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma. Curr Med Res Opin. 2010;26:1905\u201313.","journal-title":"Curr Med Res Opin"},{"key":"413_CR32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/14740338.2012.690734","volume":"11","author":"GC Rossi","year":"2012","unstructured":"Rossi GC, Pasinetti GM, Raimondi M, Ricciardelli G, Scudeller L, Blini M, et al. Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-month, single-blind, observational study on naive ocular hypertension or glaucoma patients. Expert Opi Drug Saf. 2012;11:519\u201325.","journal-title":"Expert Opi Drug Saf"},{"key":"413_CR33","first-page":"71","volume":"8","author":"YH Hwang","year":"2014","unstructured":"Hwang YH. Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma. Clin Ophthalmol. 2014;8:71\u20132.","journal-title":"Clin Ophthalmol"},{"key":"413_CR34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-200004000-00002","volume":"9","author":"S Asrani","year":"2000","unstructured":"Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9:134\u201342.","journal-title":"J Glaucoma"},{"key":"413_CR35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.68.6.389","volume":"68","author":"S Tsukahara","year":"1984","unstructured":"Tsukahara S, Sasaki T. Postural change of IOP in normal persons and in patients with primary wide open-angle glaucoma and low-tension glaucoma. Br J Ophthalmol. 1984;68:389\u201392.","journal-title":"Br J Ophthalmol"},{"key":"413_CR36","first-page":"2912","volume":"40","author":"JH Liu","year":"1999","unstructured":"Liu JH, Kripke DF, Twa MD, Hoffman RE, Mansberger SL, Rex KM, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40:2912\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"413_CR37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/aos.12108","volume":"92","author":"M Sakamoto","year":"2014","unstructured":"Sakamoto M, Kanamori A, Fujihara M, Yamada Y, Nakamura M, Negi A. Assessment of IcareONE rebound tonometer for self-measuring intraocular pressure. Acta Ophthalmol. 2014;92:243\u20138.","journal-title":"Acta Ophthalmol"},{"key":"413_CR38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00347-012-2526-y","volume":"109","author":"V Witte","year":"2012","unstructured":"Witte V, Glass A, Beck R, Guthoff R. Evaluation of the self-tonometer Icare ONE in comparison to Goldmann applanation tonometry. Ophthalmologe. 2012;109:1008\u201313.","journal-title":"Ophthalmologe."},{"key":"413_CR39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1755-3768.2011.02208.x","volume":"90","author":"JY Lee","year":"2012","unstructured":"Lee JY, Yoo C, Jung JH, Hwang YH, Kim YY. The effect of lateral decubitus position on intraocular pressure in healthy young subjects. Acta Ophthalmol. 2012;90:68\u201372.","journal-title":"Acta Ophthalmol"},{"key":"413_CR40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajo.2012.08.003","volume":"155","author":"JY Lee","year":"2013","unstructured":"Lee JY, Yoo C, Kim YY. The effect of lateral decubitus position on intraocular pressure in patients with untreated open-angle glaucoma. Am J Ophthalmol. 2013;155:329\u201335.","journal-title":"Am J Ophthalmol"},{"key":"413_CR41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.ophtha.2013.01.011","volume":"120","author":"TE Lee","year":"2013","unstructured":"Lee TE, Yoo C, Kim YY. Effects of different sleeping postures on intraocular pressure and ocular perfusion pressure in healthy young subjects. Ophthalmology. 2013;120:1565\u201370.","journal-title":"Ophthalmology"},{"key":"413_CR42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ophtha.2012.09.021","volume":"120","author":"KN Kim","year":"2013","unstructured":"Kim KN, Jeoung JW, Park KH, Lee DS, Kim DM. Effect of lateral decubitus position on intraocular pressure in glaucoma patients with asymmetric visual field loss. Ophthalmology. 2013;120:731\u20135.","journal-title":"Ophthalmology"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-015-0413-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-015-0413-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-015-0413-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:20:42Z","timestamp":1559146842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-015-0413-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1007\/s10384-015-0413-1","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}